Reconstituting a BPC-157 TB-500 5mg/5mg blend requires 2 mL of bacteriostatic water to yield a concentration of 2.5 mg/mL for each peptide, and a typical daily dosage is 250–500 mcg of each. In Canada, researchers can find this blend through specialized peptide vendors, with prices ranging from CAD 80 to 150 per vial. This guide covers the exact reconstitution steps, dosage protocols, and practical considerations for using this popular healing combination.
Understanding the BPC-157 TB-500 5mg/5mg Blend
BPC-157 and TB-500 are two of the most researched peptides for tissue repair and recovery. BPC-157, a pentadecapeptide derived from gastric juice, promotes angiogenesis and accelerates healing of tendons, ligaments, and the gut. TB-500, a synthetic fragment of thymosin beta-4, enhances cell migration and reduces inflammation. When combined in a 5mg/5mg lyophilized powder, they offer a synergistic approach to healing.
This blend is typically supplied in a single vial containing 5 mg of BPC-157 and 5 mg of TB-500. Researchers in Canada often seek this combination for its convenience and potential to amplify recovery from injuries. Before use, the powder must be reconstituted with a sterile solvent, most commonly bacteriostatic water.
Step-by-Step Reconstitution Process
Proper reconstitution is critical to maintain peptide stability and ensure accurate dosing. Follow these steps carefully:
- Gather supplies: You will need the BPC-157 TB-500 blend vial, a vial of bacteriostatic water (typically 30 mL), alcohol swabs, and a sterile syringe (1–3 mL with a 25–30 gauge needle).
- Clean the vial tops: Wipe the rubber stoppers of both the peptide vial and the bacteriostatic water vial with an alcohol swab. Allow them to dry completely to maintain sterility.
- Draw bacteriostatic water: Using the syringe, draw 2 mL of bacteriostatic water. Insert the needle into the water vial at a 45-degree angle to prevent coring, then invert and pull the plunger slowly to avoid bubbles.
- Inject into peptide vial: Insert the needle into the peptide vial at an angle, aiming the stream against the glass wall. Inject the water slowly to avoid foaming, which can damage the delicate peptides.
- Gently swirl: Do not shake the vial. Swirl it gently between your fingers until the powder dissolves completely. The solution should become clear within a minute. If it remains cloudy, allow it to sit for a few more minutes; do not use if particulate matter persists.
- Label and store: Write the reconstitution date and concentration on the vial. Store it in the refrigerator at 2–8°C. Properly reconstituted, the blend remains stable for up to 30 days.
For more on sterile technique, refer to our guide on BPC-157 reconstitution and stability. While that article focuses on single peptides, the principles apply directly to this blend.
Calculating Dosage After Reconstitution
With 2 mL of bacteriostatic water added, the concentration is 2.5 mg/mL for each peptide. This means every 0.1 mL (10 units on an insulin syringe) contains 250 mcg of BPC-157 and 250 mcg of TB-500. The standard dosage range for research is 250–500 mcg of each peptide once or twice daily.
To administer a 250 mcg dose of each, draw 0.1 mL. For a 500 mcg dose, draw 0.2 mL. Using an insulin syringe with 0.3 mL or 0.5 mL capacity allows for precise measurement. Always double-check your math: desired dose (mcg) divided by concentration (2,500 mcg/mL) equals volume in mL.
Dosage Chart for Quick Reference
- 250 mcg each: 0.1 mL (10 units)
- 350 mcg each: 0.14 mL (14 units)
- 500 mcg each: 0.2 mL (20 units)
- 750 mcg each: 0.3 mL (30 units), less common, for advanced protocols
Researchers should start at the lower end (250 mcg twice daily) and adjust based on observed effects. The total daily dose of each peptide typically does not exceed 1 mg.
Recommended Dosage Protocols
Dosage protocols vary depending on the research goal. For acute injuries like muscle tears or ligament sprains, a common approach is 250–500 mcg of each peptide twice daily, injected subcutaneously near the injury site. For chronic conditions or gut healing, once-daily dosing may suffice. A typical cycle lasts 4–6 weeks, followed by a 2-week break to prevent tolerance.
Some researchers prefer a loading phase: 500 mcg twice daily for the first week, then 250 mcg twice daily for the remaining 5 weeks. This is based on anecdotal reports of faster initial results. However, no formal studies have established an optimal protocol for the blend, so conservative dosing is prudent.
Injection timing can be flexible, but many administer doses on an empty stomach, especially if targeting gut issues. For localized injuries, injecting as close to the site as possible (subcutaneous or intramuscular) is thought to enhance local effects, though both peptides have systemic activity.
Where to Find BPC-157 TB-500 Blend in Canada
In Canada, the BPC-157 TB-500 5mg/5mg blend is available through online research peptide suppliers. Prices typically range from CAD 80 to CAD 150 per vial, depending on the vendor and any bulk discounts. It's essential to choose a supplier that provides third-party purity testing and ships discreetly within Canada to avoid customs issues.
When searching for a source, look for vendors with positive reviews on independent forums and transparent lab reports. The blend is not approved by Health Canada for human use, so it is sold strictly for research purposes. Always verify that the product is lyophilized and shipped with cold packs if required, though the blend is stable at room temperature for short periods.
Comparing BPC-157 and TB-500: Why a Blend?
While BPC-157 and TB-500 are effective individually, their mechanisms complement each other. BPC-157 primarily stimulates growth factor receptors and promotes blood vessel formation, while TB-500 upregulates actin, a protein essential for cell movement and structure. Together, they may accelerate healing more than either alone. For a deeper comparison, see our article on BPC-157 vs TB-500 for recovery.
Using a pre-mixed blend simplifies dosing and reduces the number of injections. However, some researchers prefer separate vials to adjust individual dosages. The blend is ideal for those who want a fixed ratio and convenience.
Safety and Handling Considerations
Always practice aseptic technique during reconstitution and administration. Use a new sterile syringe and needle for each injection to prevent contamination. Rotate injection sites to avoid lipoatrophy or irritation. Common sites include the abdomen, thigh, or near the injury.
Side effects are rare but may include mild redness at the injection site, fatigue, or headaches. These typically resolve quickly. There are no known severe adverse effects at research dosages, but long-term safety data is limited. Researchers should monitor for any unexpected reactions and discontinue use if necessary.
Stability and Storage After Reconstitution
Once reconstituted, the blend should be stored in a sterile vial at 2–8°C. Avoid freezing, as ice crystals can denature the peptides. With proper handling, the solution remains potent for 3–4 weeks. Some researchers report using it for up to 30 days without significant degradation, but it's best to use it within 21 days for optimal results.
If you notice any discoloration, cloudiness, or particulate matter, discard the vial immediately. To extend shelf life, consider pre-loading syringes and freezing them, though this is not recommended for the blend due to potential peptide interactions.
Frequently Asked Questions
Can I reconstitute with sterile water instead of bacteriostatic water?
Bacteriostatic water is preferred because it contains 0.9% benzyl alcohol, which inhibits bacterial growth. Sterile water can be used if the entire vial will be used within a few days, but it increases the risk of contamination over time.
How long does the reconstituted blend last at room temperature?
It should not be left at room temperature for more than a few hours. Always refrigerate after reconstitution. If you need to travel, use an insulated cooler with ice packs.
Is the BPC-157 TB-500 blend legal in Canada?
It is legal to purchase for research purposes only, not for human consumption. Researchers must comply with local regulations and institutional guidelines.
Practical Tips for Canadian Researchers
When ordering the BPC-157 TB-500 blend in Canada, consider shipping times and customs. Domestic suppliers avoid border delays, ensuring faster delivery and maintaining cold chain integrity. Some vendors offer same-day shipping within major cities like Toronto, Vancouver, or Montreal.
Keep detailed records of your research, including batch numbers, reconstitution dates, and dosage logs. This helps track results and identify any variability between vials. For reconstitution guidance on other peptides, our article on Vesugen reconstitution and solubility offers insights into handling sensitive compounds.
Expected Results and Research Outcomes
In animal studies and anecdotal reports, the BPC-157 TB-500 blend has shown promise in accelerating recovery from tendon and ligament injuries, reducing inflammation, and improving gut health. Researchers often note reduced pain and faster return to function within 2–4 weeks. However, individual results vary based on the injury type, dosage, and overall health of the subject.
For muscle recovery, the blend may enhance satellite cell activation and angiogenesis, leading to quicker repair after intense exercise. Some researchers combine it with other peptides like CJC-1295 or Ipamorelin for synergistic effects on growth hormone release, though this